Jay S. Duker
, MD, Director of the New England Eye Center
, discusses the unmet need for patients with wet and dry macular degeneration
. Dr. Duker discusses alternative forms of treatment currently in development including anti-PDGF agents
and antioxidants within a patient's diet.
Consulting Fees: Novartis, QLT, EMD Serono, ThromboGenics, Optos
Contracted Research: Carl Zeiss Meditec, Optovue
Ownership Interest: EyeNetra, Hemera, Ophthotech, Paloma